Hemophilia A and B Clinical Trial
Official title:
World Bleeding Disorders Registry Pilot Phase
The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, observational, World Bleeding Disorders Registry (WBDR). This pilot phase will assess the feasibility of conducting an expanded WBDR to more centres with a more comprehensive case report form, around the world.
The pilot phase of the WBDR is an observational disease registry of patients with hemophilia.
Forty hemophilia treatment centres (HTCs), of varying levels of economic development
(emerging, mid-level and established), that have data entry capabilities and the ability to
obtain the required data on patients in English, were invited to participate in the pilot
phase. Participating HTCs will complete a Minimal Data Set (MDS) of data on approximately 10
patients each.
A series of performance indicators have been identified by the Steering committee and will be
used to assess the feasibility of expanding the pilot phase to the WBDR. The performance
indicators include: proportion of HTCs invited that are willing to participate; proportion of
participating HTCs who successfully obtain necessary regulatory approvals; proportion of
patients approached who consent to participate; proportion of enrolled patients on which data
collection and database entry is successful.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04055051 -
ATHN 11: Liver Transplantation Outcomes Study
|
||
| Terminated |
NCT03597022 -
Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors
|
Phase 2 |